Radiotherapy & Oncology
Volume 94, Issue 1 , Pages 60-66, January 2010

A treatment planning study comparing helical tomotherapy with intensity-modulated radiotherapy for the treatment of anal cancer

  • Kurian Jones Joseph

      Affiliations

    • Division of Radiation Oncology
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, Canada TG6 1Z2.
  • ,
  • Alasdair Syme

      Affiliations

    • Division of Medical Physics, Department of Oncology, University of Alberta, Edmonton, Canada
  • ,
  • Cormac Small

      Affiliations

    • Division of Radiation Oncology
  • ,
  • Heather Warkentin

      Affiliations

    • Division of Medical Physics, Department of Oncology, University of Alberta, Edmonton, Canada
  • ,
  • Harvey Quon

      Affiliations

    • Division of Radiation Oncology
  • ,
  • Sunita Ghosh

      Affiliations

    • Division of Experimental Oncology and
  • ,
  • Colin Field

      Affiliations

    • Division of Medical Physics, Department of Oncology, University of Alberta, Edmonton, Canada
  • ,
  • Nadeem Pervez

      Affiliations

    • Division of Radiation Oncology
  • ,
  • Keith Tankel

      Affiliations

    • Division of Radiation Oncology
  • ,
  • Samir Patel

      Affiliations

    • Division of Radiation Oncology
  • ,
  • Nawaid Usmani

      Affiliations

    • Division of Radiation Oncology
  • ,
  • Diane Severin

      Affiliations

    • Division of Radiation Oncology
  • ,
  • Tirath Nijjar

      Affiliations

    • Division of Radiation Oncology
  • ,
  • Gino Fallone

      Affiliations

    • Division of Medical Physics, Department of Oncology, University of Alberta, Edmonton, Canada
  • ,
  • John Pedersen

      Affiliations

    • Division of Radiation Oncology

Received 26 November 2008; received in revised form 28 September 2009; accepted 3 October 2009. published online 06 November 2009.

Abstract 

Purpose

A planning study to compare helical tomotherapy (HT) and intensity-modulated radiotherapy (IMRT) for the treatment of anal canal cancer.

Materials and methods

Sixteen (8 males and 8 females) patients with anal cancer previously treated radically were identified. HT and IMRT plans were generated and dosimetric comparisons of the plans were performed. The planning goals were to deliver 54Gy to the tumor (PTV54Gy) and 48Gy to the nodes at risk (PTVNode) in 30 fractions.

Results

PTVs: HT plans were more homogeneous for both men and women. Male patients: HT vs. IMRT: Dmax: 55.87±0.58 vs. 59.17±3.24 (p=0.036); Dmin: 52.91±0.36 vs. 44.09±6.84 (p=0.012); female patients: HT vs. IMRT: Dmax: 56.14±0.71 vs. 59.47±0.81 (p=0.012); Dmin: 52.36±0.87 vs. 50.97±1.42 (p=0.028). OARs: In general, HT plans delivered a lower dose to the peritoneal cavity, external genitalia and the bladder and IMRT plans resulted in greater sparing of the pelvic bones (iliac crest/femur) for both men and women. Iliac crest/femur: the difference was significant only for the mean V10Gy of iliac crest in women (p0.012). External genitalia: HT plans achieved better sparing in women compared to men (p0.046). For men, the mean doses were 18.96±3.17 and 15.72±3.21 for the HT and IMRT plan, respectively (p0.017). Skin: both techniques achieved comparable sparing of the non-target skin (p=NS).

Conclusions

HT and IMRT techniques achieved comparable target dose coverage and organ sparing, whereas HT plans were more homogeneous for both men and women.

Keywords: Anal cancer, IMRT, Tomotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented in part at the annual meeting of the Canadian Association of Radiation Oncology on October 9–13, 2007, Toronto, Ontario, Canada.

PII: S0167-8140(09)00569-6

doi:10.1016/j.radonc.2009.10.003

Radiotherapy & Oncology
Volume 94, Issue 1 , Pages 60-66, January 2010